SRPT Sarepta Therapeutics

Watchlist

Close Apr 26 16:00 ET

Post 17:05 ET

12.17BMarket Cap-22201P/E (TTM)

Sarepta Therapeutics Stock Analyst Ratings & Price Target

Updated: Apr 8, 2024

Based on 17 analysts giving stock ratings to Sarepta Therapeutics in the past 3 months

Strong Buy

Updated: Apr 8, 2024

The average Sarepta Therapeutics stock price target is 169.47 with a max estimate of 224.00 and a min estimate of 145.00

Review Sarepta Therapeutics earnings estimates

Receive timely notifications of rating changes

View more detailed ratings of institutions and analysts

View rating details page for historical data

Download APP

Analyst Ratings Disclaimer

Updated: Apr 8, 2024

Strong Buy

Updated: Apr 8, 2024

Overall